Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis C

Free Subscription 06.05.2019 1 BMC Gastroenterol 2 Dig Dis Sci 1 Eur J Gastroenterol Hepatol 1 Gastroenterology 1 Haemophilia 1 J Hepatol 1 Lancet Gastroenterol Hepatol 1 Lancet Infect Dis 3 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Gastroenterol

1. HSU WF, Lai HC, Su WP, Lin CH, et al
   Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents.
   BMC Gastroenterol. 2019;19:63.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

2. ZOU WY, Choi K, Kramer JR, Yu X, et al
   Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
   Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05641.
   PubMed     Text format     Abstract available
   
   
3. VOILS CI, King HA, Thorpe CT, Blalock DV, et al
   Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment.
   Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05621.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

4. CHALOUNI M, Sogni P, Miailhes P, Lacombe K, et al
   Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
   Eur J Gastroenterol Hepatol. 2019 Apr 25. doi: 10.1097/MEG.0000000000001408.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

5. LOHMANN V, Bartenschlager R
   Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk.
   Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36726.
   PubMed     Text format    
   
   

   
   Haemophilia

6. THALAPPILLIL A, Ragni MV, Comer DM, Yabes JG, et al
   Incidence and risk factors for hepatocellular cancer in individuals with haemophilia: A National Inpatient Sample Study.
   Haemophilia. 2019;25:221-228.
   PubMed     Text format     Abstract available
   
   

   
   J Hepatol

7. HONG J, Kushner T, Dieterich D, Garry D, et al
   Reducing mother-to-child transmission of HCV: Is it attainable with a multidisciplinary approach?
   J Hepatol. 2019 Apr 24. pii: S0168-8278(19)30079.
   PubMed     Text format    
   
   

   
   Lancet Gastroenterol Hepatol

8. FLANAGAN S, Kunkel J, Appleby V, Eldridge SE, et al
   Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial.
   Lancet Gastroenterol Hepatol. 2018 Nov 23. pii: S2468-1253(18)30318.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Infect Dis

9. CHEN DS
   Taiwan commits to eliminating hepatitis C in 2025.
   Lancet Infect Dis. 2019;19:466-467.
   PubMed     Text format    
   
   

   
   PLoS One

10. 
    Retraction: Role of Hepatitis C Virus Induced Osteopontin in Epithelial to Mesenchymal Transition, Migration and Invasion of Hepatocytes.
    PLoS One. 2019;14:e0216026.
    PubMed     Text format    
    
    
11. 
    Retraction: Activation of TGF-beta1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-beta1 in Hepatic Stellate Cell Activation and Invasion.
    PLoS One. 2019;14:e0216025.
    PubMed     Text format    
    
    
12. CHIKOVANI I, Ompad DC, Uchaneishvili M, Sulaberidze L, et al
    On the way to Hepatitis C elimination in the Republic of Georgia-Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study.
    PLoS One. 2019;14:e0216123.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

13. PRENTOE J, Velazquez-Moctezuma R, Augestad EH, Galli A, et al
    Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.
    Proc Natl Acad Sci U S A. 2019 Apr 30. pii: 1822002116.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: